7026275757
Chat with us
Synopsis
Table of Contents
Introduction
Schizophrenia is a growing mental health concern, affecting roughly 23 million people worldwide, according to the World Health Organisation (WHO). It is a psychotic disorder that affects how a person perceives reality. It often develops gradually and affects behaviour and daily functioning.
For over 70 years, the treatment for schizophrenia has mainly focused on the positive symptoms. These are the most noticeable ones categorised as hallucinations, delusions, and disorganised thinking. As a result, the negative symptoms like limited speech, lack of motivation, and social withdrawal go unaddressed. The same is the case with cognitive impairment associated with schizophrenia.
The latest treatment for schizophrenia focuses on expanding the scope of symptom management and improving quality of life.
Current Advances in Schizophrenia Care
A complete cure for schizophrenia is still not known, but to understand what the latest treatment for schizophrenia is, it helps to look at the new approaches evolving through cutting-edge research. The emerging strategies focus on how treatment focuses on different areas and improves the overall quality of life. To that end, the latest advancements include:
- Looking Beyond Dopamine
As symptoms like disoriented beliefs were prioritised for years, most treatments worked by targeting dopamine, as the dysregulation of this neurotransmitter causes schizophrenia symptoms. While this is significant, new approaches extend the focus to different brain pathways, such as muscarinic receptors (particularly M1 and M2 receptors). These are proteins in the brain that regulate cognitive function while also indirectly impacting dopamine release. This results in a comprehensive approach. - Long-Acting Injectables:
To increase adherence and make daily management of schizophrenia easier, another practical advancement comes in the form of long-acting injectables. These are antipsychotics that act like a pill but are injected for a slow release of medication into the blood over a long period. They reduce the struggle of taking daily medication and reduce relapses. - Emphasis on Personalised Care
Recent research is increasingly focused on individualised treatment for schizophrenia. Beyond the diagnosis, understanding the experiences, social struggles, and behaviour of an individual and their preferences can improve outcomes. This includes selecting the right type of medication and dosage based on response and personalising therapies like CBT and behavioural support.
A Deep Dive into Newer Medications & Formulations
The recent breakthrough in schizophrenia treatment mainly comes from clinical research and testing of new medications. They include:
Cobenfy (Previously KarXT)
Cobenfy, approved by the US Food and Drug Administration (FDA), combines xanomeline and trospium chloride that target muscarinic receptors, unlike the traditional psychotics.
It’s proven to work on both positive and negative symptoms and shows potential in improving cognitive impairment. Its effectiveness was observed in two 5-week studies based on rating scales for symptom management cognition function.
The xanomaline component of Cobenfy can cause side effects such as nausea and vomiting as it interacts with receptors in the stomach and intestines. The trospium chloride in it counteracts these side effects, but caution is advised against its effect on the bladder. People with liver problems may face a higher risk of side effects.
TAAR1 Agonists
TAAR1 agonists are an emerging medication for schizophrenia treatment. They are currently in a clinical development stage. From what is known so far, they are expected to offer a novel symptom management without blocking dopamine D2 receptors. A similar alternative mediation approach to Cobenfy.
It has been shown to help control brain circuits involved in movement and behaviour by influencing chemical signalling. However, this is based on animal testing, and further analysis on its human impact is still needed to confirm its safety and effectiveness.
Glutamate Modulators
Besides dopamine, glutamate plays a major role in thinking, memory, learning, and brain communication. Abnormal glutamate is believed to contribute to schizophrenia symptoms such as cognitive impairment and social withdrawal.
Researchers are conducting clinical trials for NMDA experimental glutamate modulators such as Evenamide. This experimental drug, if proven effective, is being considered by researchers as an add-on treatment.
Innovation in Non-Medication Therapies
Alongside a difference in approach and medication, newer psychosis interventions are being used to improve daily functioning and long-term recovery.
Digital Therapeutics
Digital tools, including app-based and software-driven therapies, are being used and further explored to support remote monitoring and symptom tracking.
It is a way for psychiatrists to engage with patients conveniently without clinical visits, especially for consistent support in real-life settings. Digital therapeutics allow treatment through smartphones and virtual reality.
Cognitive Remediation
Besides the positive and negative symptoms, cognitive impairment is a significant effect of schizophrenia. A wide range of cognitive abilities, like memory, reasoning, problem solving, attention, speed of processing, executive functions, and social cognition, are affected.
Cognitive remediation is a structured therapy that strengthens these thinking patterns. Research shows that repeated cognitive exercises combined with behavioural and skills training have shown successful outcomes.
TMS Therapy
Transcranial Magnetic Stimulation (TMS) is a non-invasive therapy that uses magnetic pulses to stimulate brain regions linked to schizophrenia symptoms. It is mainly being explored for its effect on hallucinations.
It is also proven effective for negative symptoms like reduced motivation, emotional withdrawal, and cognitive difficulties. Findings suggest the use of TMS therapy as an adjunct treatment. Since it requires precise brain targeting and monitoring, schizophrenia specialists are trained in advanced neurostimulation as part of schizophrenia care.
Personalised and Precision Psychiatry
With the newest treatments for schizophrenia, the approach is gradually advancing to a more precise treatment planning. Decisions are now focused on clinical data rather than general patterns. Research and recent studies are supporting this cutting-edge shift to respond better to the individual needs of patients with specific therapies and medications.
Mental health care professionals now consider symptom profile, treatment history, biological response, and decoding experiences to guide care. This helps improve outcomes, especially in cases where first-line treatments prove ineffective. Precision psychiatry aims to reduce delays in finding the right intervention and improving long-term stability.
Role of Integrated Psychiatric Care
As is evident, research has progressed in multiple treatment approaches, including medications and therapies. This is because managing schizophrenia effectively often requires more than a single form of treatment. Integrated care focuses on coordinating different elements that improve stability, reduce the risk of relapse, and support daily functioning. It is backed by regular monitoring, behavioural interventions, family support, and rehabilitation services. Such structured care within a dedicated hospital for schizophrenia helps maintain continuity in long-term treatment.
FAQs
Q.How long does it take for new schizophrenia treatments to show results?
A.Some medications and therapies may start reducing symptoms within a few weeks. However, steady symptom management can take several months with consistent treatment.
Q. Are newer treatments safe for long-term use?
A.Most are still being studied for long-term safety. Nonetheless, doctors usually monitor progress closely and adjust the treatment based on the response and side effects over time.
Q. Can cognitive symptoms like memory and focus fully recover?
A.There is no evidence of complete recovery, but therapies like cognitive remediation and structured support can significantly improve these symptoms.
Q.How do doctors decide the right treatment plan?
A.They consider symptom patterns, past response to medication, side effects, and overall functioning before planning a treatment and adjust it along the way.
Disclaimer:
The information provided on this page is for educational purposes only and does not replace professional medical consultation. Insomnia treatment results vary from person to person. Please consult a specialist psychiatrist or psychologist for personalised care. If you or your loved one is struggling with Insomnia, reach out to Maarga Mind Care – a trusted psychiatric hospital in India. Our experts can help you start your journey to recovery.
